Melanocortin receptor agonists
US7169777B2 · kind B2 · utility
4Cited by
1References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 23, 2002 |
| Grant date | Jan 30, 2007 |
| Priority date | — |
| Expiry date | Dec 4, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to melanocortin receptor agonist of the formula I useful in the treatment of obesity, diabetes, and male and/or female sexual dysfunction
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.